Previous Close | 160.44 |
1-Year Change | 18.91% |
6-Months Change | 11.15% |
3-Months Change | 6.17% |
Moving Avg (50d) | 154 |
Moving Avg (200d) | 141.89 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 18.0B |
Beta (3-Years) | 0.45 |
Revenue Growth (ttm) | -9.69% |
Net Profit Margin (ttm) | 8.21% |
Return On Assets (ttm) | 5.66% |
EPS (ttm) | 6.71 |
PE Ratio (ttm) | 23.91 |
Dividend Yield | 1.74% |
Asset Description: | Quest Diagnostics Incorporated |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-10-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
166.862 | 171.769 | 175.041 | 179.949 | 188.128 | 196.308 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.